Good news strikes the millions of Americans that are suffering from psoriasis and psoriatic as they may be nearing to a possible solution for the said disease.
This is due to the study that the researchers from the University of Michigan Health System will be conducting in accordance to the release of the first ever National Psoriasis Victor Henschel BioBank DNA samples. These samples will then be examined in a hope that there will be cure as they find the unknown facts and factors underlying in the genetics of psoriasis and psoriatic arthritis.
Psoriasis has been one of the diseases that have been plaguing Americans and it has been one of the most rampant disease that targets the immune system these days. Around 7.5 million of American citizens have been diagnosed with the said disease. And, around 30 percent of American citizens that have diagnosed with psoriasis eventually developed a related disease in the joint called psoriatic arthritis, in the long run. Psoriasis is the disease that damages and disables the immune system. Meanwhile, the psoriatic arthritis is the most likely complication that psoriasis brings as the disease advances.
According to James T. Elder, M.D., Ph.D., the Kirk D Wuepper Professor of Molecular Genetic Dermatology, “Because we will be studying many thousands of genes, and because the genetic differences that predispose people to psoriasis can be subtle, this type of research requires thousands of cases and controls to yield statistically significant results. That’s why the large number of Biobank samples is so important.”
Meanwhile, the National Psoriasis Victor Henschel BioBank is also responsible for the huge contribution to the incoming hopeful treatments for psoriasis and psoriatic arthritis. They have contributed DNA samples of people with the said diseases. They have done this with a mission to find the unknown factors that cause psoriasis and psoriatic arthritis. Furthermore, they are hoping that the research to be conducted by experts from the University of Michigan Health System will find the cure to put an end to the dreaded disease that have plaguing around 7.5 million Americans.
According to Rick Seiden, chair of the National Psoriasis Foundation Board of Trustees, “The BioBank is a critical resource for bringing us one step closer to a cure for psoriasis, and we are honored to partner with Dr. Elder and his team on this landmark project. This endeavor would not be possible without the hundreds of people with and without psoriasis and psoriatic arthritis who donated DNA over the past four years, and we thank all of them for their huge contribution to psoriasis research.”
